Global Financial Private Capital’s AstraZeneca AZN Stock Holding History

Global Financial Private Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$3K	Sell	29 -1,223	-98%	-$126K	﹤0.01%	325
2020 Q1	$112K	Sell	1,252 -168	-12%	-$15.8K	0.01%	243
2019 Q4	$142K	Buy	1,420 +471	+50%	+$44.3K	0.01%	256
2019 Q3	$85K	Sell	949 -49	-5%	-$4.25K	﹤0.01%	272
2019 Q2	$82K	Buy	+998	New	+$78.3K	﹤0.01%	293
2019 Q1	–	Sell	-59,001	Closed	-$4.48M	–	371
2018 Q4	$4.48M	Sell	59,001 -47,257	-44%	-$3.69M	0.24%	95
2018 Q3	$8.41M	Sell	106,258 -119,653	-53%	-$9.05M	0.3%	78
2018 Q2	$15.9M	Sell	225,911 -71,282	-24%	-$5.13M	0.54%	56
2018 Q1	$20.8M	Buy	+297,193	New	+$20.6M	0.73%	38
2017 Q4	–	Sell	-382,574	Closed	-$25.9M	–	525
2017 Q3	$25.9M	Buy	382,574 +69,772	+22%	+$4.41M	0.93%	34
2017 Q2	$21.3M	Sell	312,802 -3,510	-1%	-$229K	1.03%	34
2017 Q1	$19.7M	Buy	+316,312	New	+$18.4M	0.99%	34

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Global Financial Private Capital's AZN Position: Q2 2020 in Review

Global Financial Private Capital reduced its AstraZeneca (AZN) stake by 98% in Q2 2020, selling an estimated $126K and leaving 29 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #325.

Global Financial Private Capital first reported a position in AZN in Q1 2017 and has held it in 12 quarters since. The position peaked at $25.9M in Q3 2017. 669 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

Global Financial Private Capital held 29 shares of AstraZeneca worth $3K as of Q2 2020.
Global Financial Private Capital sold 1,223 AstraZeneca shares in Q2 2020, an estimated $126K.
AstraZeneca made up ﹤0.01% of Global Financial Private Capital's portfolio in Q2 2020, its #325 holding.
Global Financial Private Capital first reported a position in AstraZeneca in Q1 2017 and has held it in 12 quarters since.
Global Financial Private Capital's AstraZeneca position peaked at $25.9M in Q3 2017.
669 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.